Biosimilars (otherwise termed follow-on-biologics, or FOBs for short) stand for the versions of biopharmaceuticals, which have the resembling but not identical parent molecule, and are created either by living organisms or from living micro-organisms by way of rDNA (recombinant DNA) or supervised gene expression technologies. The approval of Biosimilars occurs via strictly defined regulatory paths based on whether FOBs have shown comparability with their reference substance.
The worldwide Biosimilars Market is anticipated to surpass a EUR 14.9bn mark by end 2018. The major drivers encompass cost efficiency of biosimilars versus their high-priced analogues, the enlarging thirst for biotechnology drugs, imminent biotech drugs’ patent expiries, the planet’s aging population, and the rising frequency of critical illnesses. The illustrious actors on the global Biosimilars stage encompass Biocon, Intas Biopharmaceuticals, Cipla, Biopartners, Hospira, Wockhardt, Teva Pharmaceutical Industries, Sandoz International, amidst others.
The Catalogue’s research reports offer world, region and nation-wise analyses of the Biosimilars Market development over various time periods. The researches are lavish with discussions of the Biosimilars Industry growth rate, structure and capacity. The market trends, growth obstacles/stimulators, key products and those in R&D stage, and more issues are studied in the reports. Additionally, the research reports indicate and profile the leading players and hoped-for entrants, and offer market projections and forecasts.
Publications found:
167
Sort by:
Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region – Global Forecast to 2028
US$ 4,950.00
... the forecast period.” The biosimilars market by product, is categorized into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant glycosylated proteins segment is expected ...
June 2023
298 pages
Asia Pacific Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimmune Disease, Blood Disorder, Diabetes), Manufacturing (Contract, Inhouse), End User (Hospitals and Clinics, Research Institutes), and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
Asia Pacific biosimilars market will grow by 30.7% annually with a total addressable market cap of $140.4 billion over 2021-2030 owing to the affordability of biosimilar-based treatment, rising incide...
November 2021
116 pages
Europe Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimmune Disease, Blood Disorder, Diabetes), Manufacturing (Contract, Inhouse), End User (Hospitals and Clinics, Research Institutes), and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
Europe biosimilars market was valued at $5,847.6 million in 2020 and will grow by 23.1% annually over 2020-2030 owing to the affordability of biosimilar-based treatment, rising incidence of chronic di...
November 2021
121 pages
Global Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimmune Disease, Blood Disorder, Diabetes), Manufacturing (Contract, Inhouse), End User (Hospitals and Clinics, Research Institutes), and Region: Trend Forecast and Growth Opportunity
US$ 2,720.00
Global biosimilars market will reach $113.25 billion by 2030, growing by 25.7% annually over 2020-2030 driven by the affordability of biosimilar-based treatment, rising incidence of chronic diseases d...
November 2021
180 pages
North America Biosimilars Market 2020-2030 by Product Type (Non-glycosylated, Glycosylated), Indication (Cancer, Autoimmune Disease, Blood Disorder, Diabetes), Manufacturing (Contract, Inhouse), End User (Hospitals and Clinics, Research Institutes), and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
North America biosimilars market is expected to grow by 25.1% annually in the forecast period and reach $27.57 billion by 2030 driven by the affordability of biosimilar-based treatment, rising inciden...
November 2021
116 pages
Asia Pacific BOPP and BOPET films Market Analysis: Plant Capacity, Production, Operating Efficiency, Process, Demand & Supply, Application, Sales Channel, Region, Competition, Trade, Customer & Price Intelligence Market Analysis, 2015-2030
US$ 4,000.00
Asia Pacific BOPP and BOPET films demand stood at 2.09 Million Tonnes in 2020 and is forecast to reach 3.476 Million Tonnes by 2030, growing at a healthy CAGR of 5.04% until 2030. The rise in e-commer...
June 2021
Biosimilars: Global Markets
US$ 2,750.00
... emerging framework in regulated markets, as well as comparisons of biosimilar guidelines in Europe, the U.S., Japan, Canada, as well the guidelines developed by the - World Health Organization Technology trends and ...
May 2021
358 pages
Global Glycobiology Market, By Product (Enzymes, Instruments, Reagents and Kits), By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region, Competition, Forecast & Opportunities, 2025
US$ 4,500.00
Global glycobiology market was valued at USD 938.76 Million in 2019 and is expected to grow at a double digit CAGR of 13.83% during the forecast period. The global glycobiology market is driven by the...
January 2021
224 pages
Biosimilars Market by Product (Insulin, rhGH, Granulocyte colony-stimulating factor, Interferon, Erythropoietin, Etanercept, Monoclonal antibodies, Follitropin, Glucagon, Calcitonin, Teriparatide, and Enoxaparin Sodium), By Manufacturing (In-house, Contract) & Indication (Offsite Treatment, Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease, Blood Disorders, Infectious Disease, and Other Diseases), By Geography (North America, Europe, APAC, and RoW) Global Opportunity Analysis and Industry Forecast up to 2026
US$ 3,250.00
Biosimilars Market by Product (Insulin, rhGH, Granulocyte colony-stimulating factor, Interferon, Erythropoietin, Etanercept, Monoclonal antibodies, Follitropin, Glucagon, Calcitonin, Teriparatide, and...
July 2020
85 pages
Global Biosimilars - Market and Technology Forecast to 2028
US$ 3,995.00
Biosimilars have a very complex molecular structure and they have similar characteristics as compared to their reference medicine. Biosimilars are mainly used to derive known effective medicinal produ...
June 2020
256 pages
Japan Biosimilars- Landscape Today Outlook Tomorrow
US$ 4,500.00
“Biosame” entry, uninterrupted supply and companies’ strong front-end footprint requirement makes it distinctAfter a decade, JP Biosimilar guideline’s first revision expected in FY2020 –Demonstrate Ch...
January 2020
156 pages
Europe Biosimilar Insulin Glargine & Lispro Market, By End User (Type 1 Diabetes and Type 2 Diabetes),By Country (Germany, United Kingdom, France, Italy, Spain, Russia, Turkey, Poland, The Netherlands, Austria & Rest of Europe), Competition, Forecast & Opportunities, 2024
US$ 4,000.00
Europe biosimilar insulin glargine and lispro market is projected to reach $ 1.9 billion by 2024 owing to rising levels of obesity, growing expenditure on healthcare and increasing adoption of sedenta...
January 2020
86 pages
US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025
US$ 2,400.00
... Phase: 28 Biosimilars Marketed Biosimilars Clinical Insight by Company & Indication: 9 Biosimilars Biosimilars Market Opportunity: US$ 5 Billion FDA Rules & Regulations For Biosimilars Development & Market Approved & Marketed Biosimilars: Clinical Insight, Price & Dosage 'US Biosimilars Market, Dosage, Price ...
April 2019
300 pages
Global G-CSF Biosimilars Market Size study, by Type (Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor), By Application (Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases, Growth Hormone Deficiencies) and Regional Forecasts 2018-2025
US$ 3,950.00
... – 2018 to 2025 Target Audience of the Global G-CSF Biosimilars Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...
February 2019
200 pages
Biosimilars: Market Research Report
US$ 5,450.00
This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for the US, ... forecasts are provided for the period 2015 through 2022. Market data and analytics are derived from primary and secondary ...
January 2019
243 pages
ASEAN and China Biosimilars Market by Molecule Type (Human Growth Hormone, Erythropoietin, Monoclonal Antibody, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, and Peptide), and Application (Blood Disorder, Oncology Disease, Chronic & Autoimmune Disease, Growth Hormone Deficiency, and Others): Opportunity Analysis and Industry Forecast, 2017 - 2025
US$ 3,200.00
... the expansion of the biosimilars market across ASEAN and China. The ASEAN and China biosimilars market is segmented into molecule ... market is analyzed across China and ASEAN region. Key Benefits ASEAN and China Biosimilars Market: The study provides an in-depth analysis of the ASEAN and China biosimilars market ...
November 2018
130 pages
Biosimilars: US Payer Perspectives (2018)
US$ 2,495.00
... 2018). You won't find entrenched perceptions, old data and out-of-date opinions. Instead, Biosimilars: US Payer Perspectives ... Example insight included in Biosimilars: US Payer Perspectives Payers have devised strategies to encourage the adoption of biosimilars. Currently, payers require prior authorisations, ...
March 2018
Global Biosimilars Market 2018-2024
US$ 3,000.00
... the growth this market to a large extent. Market Analysis: The “Global Biosimilars Market” is estimated to witness a CAGR of 57.03% during the forecast period 2018–2024. The market is analyzed based on three ...
March 2018
120 pages
Biosimilars-Asia Pacific Market Status and Trend Report 2013-2023
US$ 3,480.00
... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Biosimilars market as: Asia Pacific Biosimilars Market ...
February 2018
150 pages
Biosimilars-China Market Status and Trend Report 2013-2023
US$ 2,980.00
... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the China Biosimilars market as: China Biosimilars Market: Regional ...
February 2018
141 pages
Biosimilars-EMEA Market Status and Trend Report 2013-2023
US$ 3,480.00
Report Summary Biosimilars-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilars industry, standing on the readers’ perspective, delivering detailed market data and penetrating ...
February 2018
146 pages
Biosimilars-Europe Market Status and Trend Report 2013-2023
US$ 3,480.00
... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the Europe Biosimilars market as: Europe Biosimilars Market: Regional ...
February 2018
137 pages
Biosimilars-Global Market Status and Trend Report 2013-2023
US$ 2,480.00
Report Summary Biosimilars-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilars industry, standing on the readers’ perspective, delivering detailed market data and penetrating ...
February 2018
153 pages
Biosimilars-India Market Status and Trend Report 2013-2023
US$ 2,980.00
... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the India Biosimilars market as: India Biosimilars Market: Regional ...
February 2018
144 pages
Biosimilars-North America Market Status and Trend Report 2013-2023
US$ 3,480.00
... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the North America Biosimilars market as: North America Biosimilars Market ...
February 2018
132 pages
Biosimilars-South America Market Status and Trend Report 2013-2023
US$ 3,480.00
... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the South America Biosimilars market as: South America Biosimilars Market ...
February 2018
135 pages
Biosimilars-United States Market Status and Trend Report 2013-2023
US$ 3,480.00
... Biosimilars market Market status and development trend of Biosimilars by types and applications Cost and profit status of Biosimilars, and marketing status Market growth drivers and challenges The report segments the United States Biosimilars market as: United States Biosimilars Market ...
February 2018
140 pages
Biosimilars: EU Payer Perspectives
US$ 2,495.00
... relation to Humira biosimilars Future challenges and opportunities in the European biosimilars market Example insight included in Biosimilars: EU Payer Perspectives 'Aligned with ... been hugely successful.' Example quote included in Biosimilars: EU Payer Perspectives 'There have been huge cost savings over ...
January 2018
Biosimilars Market, 2012 to 2023
US$ 4,400.00
... , Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 Global Biosimilars Market Report Description: Global biosimilars market report gives a comprehensive outlook on biosimilars products across the ...
January 2018
192 pages
Charting the Global Biosimialr pipeline
US$ 745.00
... and many other questions can be found in Charting the Global Biosimilars Pipeline. This comprehensive report provides the most detailed evaluation ... biosimilar companies Biosimilar pipeline by product BIOSIMILAR PIPELINE BY PRODUCT Each biosimilar monograph utilises well-structured tables and charts to provide ...
December 2017
Biosimilar Insulin-Asia Pacific Market Status and Trend Report 2013-2023
US$ 3,480.00
... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Biosimilar Insulin market as: Asia Pacific Biosimilar Insulin Market ...
December 2017
135 pages
Biosimilar Insulin-China Market Status and Trend Report 2013-2023
US$ 2,980.00
... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the China Biosimilar Insulin market as: China Biosimilar Insulin Market ...
December 2017
132 pages
Biosimilar Insulin-EMEA Market Status and Trend Report 2013-2023
US$ 3,480.00
Report Summary Biosimilar Insulin-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biosimilar Insulin industry, standing on the readers’ perspective, delivering detailed market data and ...
December 2017
135 pages
Biosimilar Insulin-Europe Market Status and Trend Report 2013-2023
US$ 3,480.00
... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the Europe Biosimilar Insulin market as: Europe Biosimilar Insulin Market ...
December 2017
132 pages
Biosimilar Insulin-India Market Status and Trend Report 2013-2023
US$ 2,980.00
... Biosimilar Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the India Biosimilar Insulin market as: India Biosimilar Insulin Market ...
December 2017
130 pages
Biosimilar Insulin-North America Market Status and Trend Report 2013-2023
US$ 3,480.00
... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the North America Biosimilar Insulin market as: North America Biosimilar Insulin Market ...
December 2017
154 pages
Biosimilar Insulin-South America Market Status and Trend Report 2013-2023
US$ 3,480.00
... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the South America Biosimilar Insulin market as: South America Biosimilar Insulin Market ...
December 2017
158 pages
Biosimilar Insulin-United States Market Status and Trend Report 2013-2023
US$ 3,480.00
... Insulin market Market status and development trend of Biosimilar Insulin by types and applications Cost and profit status of Biosimilar Insulin, and marketing status Market growth drivers and challenges The report segments the United States Biosimilar Insulin market as: United States Biosimilar Insulin Market ...
December 2017
151 pages
Hereceptin Biosimilar-Asia Pacific Market Status and Trend Report 2013-2023
US$ 3,480.00
... Hereceptin Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Hereceptin Biosimilar market as: Asia Pacific ...
December 2017
137 pages
Hereceptin Biosimilar-China Market Status and Trend Report 2013-2023
US$ 2,980.00
... Biosimilar market Market status and development trend of Hereceptin Biosimilar by types and applications Cost and profit status of Hereceptin Biosimilar, and marketing status Market growth drivers and challenges The report segments the China Hereceptin Biosimilar market as: China Hereceptin Biosimilar Market ...
December 2017
141 pages
